#srpt

1 story

#biotech stocks #investor sentiment #market volatility #sarepta therapeutics #sector selloff #stock decline

Sarepta plunges 7.1% in biotech selloff
Cambridge biotech firm caught in sector-wide downturn with no company-specific news driving the decline.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m